AI assistant
DAVITA INC. — Director's Dealing 2015
Feb 2, 2015
30643_dirs_2015-02-02_c4e5d8f6-b30d-47ad-ae42-97562897d554.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2015-01-29
Reporting Person: Margolis Robert J (Director, Co-Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-29 | Common Stock | S | 15700 | $75.4935 | Disposed | 2645002 | Indirect |
| 2015-01-30 | Common Stock | S | 15700 | $75.4733 | Disposed | 2629302 | Indirect |
Footnotes
F1: The sales reported herein were affected pursuant to a Rule 10b5-1 trading plan adopted on September 18, 2014 by The Robert and Lisa Margolis Family Trust dated 7/27/2000 of which the reporting person is a trustee.
F2: Represents the weighted average sale price of $75.4935. The range of prices for the sale of these shares was $75.03 - $76.15, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F3: Represents the weighted average sale price of $75.4733. The range of prices for the sale of these shares was $75.06 - $75.92, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F4: The Robert and Lisa Margolis Family Trust dated 7/27/2000.